Long-term treatment of obese & overwt patients, including patients w/ risk factors associated w/ obesity, in conjunction w/ a mildly hypocaloric diet. Treatment results in an improvement of risk factors & comorbidities associated w/ obesity, including hypercholesterolemia, NIDDM, impaired glucose tolerance, hyperinsulinemia, HTN & a reduction of visceral fat. Provides additional glycaemic control in combination w/ antidiabetic agents eg, metformin, sulfonylurea &/or insulin in type 2 diabetic patients who are overwt (BMI >28 kg/m2) or obese (BMI >30 kg/m2), in conjunction w/ a mildly hypocaloric diet.
View Xenical overdosage for action to be taken in the event of an overdose.
Administration
Should be taken with food: Take immediately before or during or up to 1 hr after each main meal. If a meal is missed or contains no fat, the dose may be omitted.
Sign Out
